Science, Discovery, Tech and Environment · 2 January 2026
Union Minister J P Nadda announces India ranks 8th globally in World Health Organization (WHO) Pharmacovigilance Contributions
Exam-focused facts from the 2 January 2026 current affairs briefing.
Key facts
- India now stands at the 8th position globally in World Health Organization (WHO) Pharmacovigilance Contributions, rising from the 123rd position held ten years ago.
- The Ministry of Health and Family Welfare released the 10th edition of the Indian Pharmacopoeia (IP) 2026, which serves as the official book of drug standards for India.
- The Indian Pharmacopoeia (IP) 2026 has incorporated 121 new monographs, increasing the total count to 3,340 monographs.
- India has become the first country to include 20 blood component monographs to expand research in blood transfusion, thalassemia, hemophilia, and anaemia.
- The new monographs are designed to benefit the National TB Elimination Programme, Anaemia Mukt Bharat, and the Universal Immunisation Programme.
- The Indian Pharmacopoeia (IP) is currently recognized as a standard in 19 Global South countries.